Can we predict Chemo's heart harm? new study aims to find out
NCT ID NCT01173341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 700 breast cancer patients to understand how chemotherapy affects the heart. Researchers use echocardiograms and blood tests to find early signs of heart damage. The goal is to better predict and prevent cardiotoxicity in cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict and prevent heart damage in breast cancer patients receiving chemotherapy.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and results depend on long-term follow-up over 10 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?